Complement C4 monitoring in the follow-up of chronic hepatitis C treatment
- 1 January 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 127 (1), 131-136
- https://doi.org/10.1046/j.1365-2249.2002.01729.x
Abstract
Summary: The overall role of complement in the host–pathogen relationship is now well understood. However, its involvement at a chronic stage of infection, such as chronic hepatitis C, is less well documented. Here, results are reported which point to the use of specific C4 monitoring in the follow-up of HCV patients. This study concerns 66 patients with chronic HCV infection, treated with interferon alpha 2b alone or with interferon alpha 2b + ribavirin, and 50 healthy adults as controls. Complement blood tests were performed to measure C1q, C3, C4, mannan binding lectin (MBL), C1s-C1 inhibitor complexes, total (CH50) and C4 (C4H) haemolytic activity; specific C4 activity was taken as the C4H/C4 protein ratio. Rheumatoid factor (RF) levels were also measured. A significant reduction in CH50 and specific C4 activity in HCV patients, compared with the healthy controls, was observed before the onset of treatment; the other parameters were not affected and no C1s-C1 inhibitor complexes were detected. At the same time, a significant reduction in specific C4 activity was observed in relapsers compared with sustained responders. These results point to a potential predictive function of C4 specific activity to monitor the response to therapy. Restoration of specific C4 activity at 6 months was better in responders than in non-responders. Complement activation in chronic hepatitis C does not seem to involve the C1 stage of the classical pathway. A negative correlation between specific C4 activity and RF titres suggests a possible involvement of RF in C4 activation, via the lectin pathway. Specific C4 monitoring appears to be a valuable tool for the follow-up of chronic hepatitis C treatment, together with the other conventional investigations.This publication has 36 references indexed in Scilit:
- Hepatitis C and D, Retroviruses and Autoimmune ManifestationsJournal of Autoimmunity, 2001
- Hepatitis C virus (HCV) infection and cryoglobulinemia: Analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histologyJournal of Hepatology, 2000
- Viral interference with antibody and complementSeminars in Cell & Developmental Biology, 1998
- Evidence That Hepatitis C Virus Resistance to Interferon Is Mediated through Repression of the PKR Protein Kinase by the Nonstructural 5A ProteinVirology, 1997
- Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding proteinNature Medicine, 1995
- Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease.The Journal of Experimental Medicine, 1992
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis.Annals Of The Rheumatic Diseases, 1987
- Methods to Detect and Quantitate Complement ActivationPublished by Springer Science and Business Media LLC ,1985
- Methods to detect and quantitate complement activationSpringer Seminars in Immunopathology, 1983